Eruptive papules during efalizumab (anti-CD11a) therapy of psoriasis vulgaris: a case series

BACKGROUND: Newer biological therapies for moderate-to-severe psoriasis are being used more frequently, but unexpected effects may occur. CASE PRESENTATIONS: We present a group of 15 patients who developed inflammatory papules while on efalizumab therapy (Raptiva, Genentech Inc, anti-CD11a). Immunoh...

Descripción completa

Detalles Bibliográficos
Autores principales: Lowes, Michelle A, Chamian, Francesca, Abello, Maria V, Leonardi, Craig, Dummer, Wolfgang, Papp, Kim, Krueger, James G
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1817648/
https://www.ncbi.nlm.nih.gov/pubmed/17324275
http://dx.doi.org/10.1186/1471-5945-7-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1817648/
https://www.ncbi.nlm.nih.gov/pubmed/17324275
http://dx.doi.org/10.1186/1471-5945-7-2

Ejemplares similares